Novavax
NVAX
#5428
Rank
C$1.92 B
Marketcap
C$11.80
Share price
1.43%
Change (1 day)
23.93%
Change (1 year)

Novavax (NVAX) - Total debt

Total debt on the balance sheet as of December 2025 : C$0.34 Billion

According to Novavax's latest financial reports the company's total debt is C$0.34 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Novavax - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-12-31C$0.34 B3.05%
2024-12-31C$0.33 B8.82%
2023-12-31C$0.30 B-59.27%
2022-12-31C$0.74 B28.94%
2021-12-31C$0.57 B-3.04%
2020-12-31C$0.59 B41.94%
2019-12-31C$0.42 B-3.31%
2018-12-31C$0.43 B8.83%
2017-12-31C$0.39 B-6.02%
2016-12-31C$0.42 B77483.14%
2015-12-31C$0.54 M-52.69%
2014-12-31C$1.15 M-42.16%
2013-12-31C$2 M67.1%
2012-12-31C$1.19 M268.12%
2011-12-31C$0.32 M-18.59%
2010-12-31C$0.39 M-21.81%
2009-12-31C$0.51 M-98.16%
2008-12-31C$27.85 M22.73%
2007-12-31C$22.69 M-15.94%
2006-12-31C$26.99 M-24.04%
2005-12-31C$35.54 M-20.37%
2004-12-31C$44.63 M-18.39%
2003-12-31C$54.69 M-16.36%
2002-12-31C$65.39 M19.55%
2001-12-31C$54.7 M82.55%
2000-12-31C$29.96 M20675.29%
1999-12-31C$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
C$48.86 B 14,118.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$88.34 B 25,606.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$40.26 B 11,615.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$32.96 B 9,491.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$1.43 B 317.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$3.22 M-99.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$63.22 M-81.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$2.07 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.60 B 76.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.91 B 166.51%๐Ÿ‡บ๐Ÿ‡ธ USA